fluorodeoxyglucose f18 has been researched along with 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvey, S; Gabrielson, E; Gabrielson, K; Hagemann, RL; Kuhajda, FP; Lee, JS; Orita, H; Pomper, MG | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid
| Article | Year |
|---|---|
FDG-PET for pharmacodynamic assessment of the fatty acid synthase inhibitor C75 in an experimental model of lung cancer.
Topics: 4-Butyrolactone; Animals; Disease Models, Animal; Enzyme Inhibitors; Fatty Acid Synthases; Fluorodeoxyglucose F18; Lung Neoplasms; Positron-Emission Tomography; Rats | 2007 |